Entity

Time filter

Source Type


Yao Q.-L.,Zhangjiagang Municipal Hospital of Traditional Chinese Medicine | Lu J.-D.,Zhangjiagang Municipal Hospital of Traditional Chinese Medicine | Xu X.-R.,Zhangjiagang Municipal Hospital of Traditional Chinese Medicine | Liu Y.-H.,Zhangjiagang Municipal Hospital of Traditional Chinese Medicine | Zhang J.-Y.,Zhangjiagang Municipal Hospital of Traditional Chinese Medicine
Journal of Interventional Radiology (China) | Year: 2015

Objective: To investigate the clinical effects and complications of uterine artery embolization (UAE) therapy using different embolic agents in treating uterine adenomyosis. Methods: During 2004-2011, a total of 45 female patients with uterine adenomyosis were admmitted to authors' hospital to receive uterine artery embolization therapy. The embolic agents used in the procedures included domestic iodized oil, sodium alginate microspheres and Embosphere microspheres. The patients were randomly divided into group A (n = 15, using domestic iodized oil as embolic agent), Group B (n = 13, using sodium alginate microspheres as embolic agent) and group C (n = 17, using Embosphere microspheres as embolic agent). After the treatment, all the patients were followed up for over 2 years, focusing on the observation of the clinical symptoms such dysmenorrhea!, changes of MRI signs and severe complications. The results were analyzed and compared among the three groups. Results: After UAE, the clinical symptoms such as the degree of dysmenorrhea, menstrual quantity, etc. were improved in all patients. Six months after UAE, the obvious remission rate of dysmenorrheal in group A, B and C was 33.3% (5/15), 30.8% (4/13) and 41.1% (7/17) respectively. Twelve months after UAE, MRI scanning showed that the uterine sizes in group A, B and C were reduced to 49.19%, 48.25% and 50.05% respectively. Follow-up examination at 24 months after UAE showed that recurrence of dysmenorrheal in group A, B and C was seen in 2, 4 and 2 cases respectively, and amenorrhea was seen in 2 cases of group A and one case in group C. Conclusion: The use of domestic iodized oil, sodium alginate microspheres or Embosphere microspheres as embolic agents in performing super - selective uterine artery embolization for adenomyosis can effectively relieve the degree of dysmenorrheal, decrease the uterine size. In addition to ovarian dysfunction, the uterine cavity adhesion may be also a possible cause of amenorrhea occurring after UAE may. In order to ensure a similar clinical efficacy, the use of granular solid embolic agent is preferred as its safety is possibly higher than the liquid embolic agents.


Yao Q.-L.,Zhangjiagang Municipal Hospital of Traditional Chinese Medicine | Lu J.-D.,Zhangjiagang Municipal Hospital of Traditional Chinese Medicine | Xu X.-R.,Zhangjiagang Municipal Hospital of Traditional Chinese Medicine | Liu Y.-H.,Zhangjiagang Municipal Hospital of Traditional Chinese Medicine | And 3 more authors.
Journal of Interventional Radiology (China) | Year: 2013

Objective: To evaluate the long-term clinical efficacy of uterine artery embolization (UAE) in treating diffuse adenomyosis. Methods: During the period from 2007 to 2012, UAE was carried out in 19 female patients with MRI-proved symptomatic diffuse adenomyosis. Follow-up examination was conducted at 6, 12, 18, 24 and 36 months after the treatment. MRI findings, the degree of dysmenorrhea and the improvement of anemia were analyzed. Results: Anemic condition was corrected in about three months after the treatment in all 19 patients. MRI showed that uterine volume decreased significantly within 12 months, with a mean reduction of 51.97%. The degree of dysmenorrhea was relieved, which was more obvious within 24 months, although a tendency to recur was seen in 7 patients after 24 months. MRI demonstrated newly-developed small lesions in 4 of the seven cases. Conclusion: For diffuse adenomyosis, UAE can significantly relieve patient's symptoms with excellent clinical results, although in some patients the clinical symptoms of dysmenorrhea may recur after two years due to the newly-developed small lesions in some patients.

Discover hidden collaborations